BioSpace News Archive

ReCode Therapeutics to Present at 40th Annual J.P. Morgan Healthcare Conference.

Agilent Technologies Inc. announced that Professor Jason Kovacic has been selected to receive a prestigious Agilent Thought Leader Award.

Scopus BioPharma Inc. announced that it has filed an amendment to the Current Report on Form 8-K that was filed by the Company on December 27, 2021 with the U.S. Securities and Exchange Commission disclosing the certified voting results of the Annual Meeting of Stockholders.

Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohealth disorders, today announced certain preliminary unaudited fourth quarter and full year 2021 revenue results.

Biomea Fusion, Inc. (“Biomea”) (Nasdaq: BMEA), announced today that in 2022 it plans to initiate clinical studies to dose its irreversible covalent menin inhibitor, BMF-219, in up to seven different cancer indications as well as in diabetes.

The Johnson & Johnson Medical Devices Companies (JJMDC)* today announced that it will collaborate with Microsoft to further enable and expand JJMDC’s secure and compliant digital surgery ecosystem.

Castle Creek Biosciences, Inc. today announced it has acquired Novavita Thera, Inc., a preclinical gene therapy company focused on rare liver and metabolic diseases.

Everest Medicines (HKEX 1952.HK, “Everest”, or the “Company”), today announced it will participate in a study pursuant to a clinical trial collaboration between Gilead and MSD to evaluate the combination of the Trop-2 targeting antibody-drug conjugate (ADC) Trodelvy.

Atara Biotherapeutics to Present Recent Progress and Key Upcoming Catalysts at the 40 th Annual J.P. Morgan Healthcare Conference.

ViewRay, Inc. (Nasdaq: VRAY) (the “Company”) today announced preliminary financial results for the fourth quarter and full fiscal year ended December 31, 2021.